Thermo Fisher Scientific

1335 articles with Thermo Fisher Scientific

• Thermo Fisher Scientific Further Expands Laboratory Plastics Production to Support COVID-19 Testing, Therapies and Vaccines

  9/15/2020

   Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it is investing more than $140 million to further expand its laboratory plastics consumables production to support significant global demand for COVID-19 testing, as well as development and manufacturing of therapies and vaccines

• Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 15, 2020

  9/14/2020

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper , chairman, president and chief executive officer, will present virtually at the Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2020 , at 8:00 a.m. (ET) . You can access the live webcast of t

• Thermo Fisher Scientific Announces Collaborations to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

  9/14/2020

  Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis   [14-September-2020]   CAMBRIDGE, Mass. , Sept. 14, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced new collaborations of the Thermo Fi

• Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis

  9/9/2020

  Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri.

• FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer

  9/8/2020

   The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic (CDx) to identify RET fusion-positive, metas

• FBI Approves Thermo Fisher Scientific's Rapid DNA Solution for National DNA Index System

  9/8/2020

  The U.S. Federal Bureau of Investigation has approved Thermo Fisher Scientific's Applied Biosystems RapidHIT ID System for use by accredited forensic DNA laboratories to process DNA reference samples and search resulting profiles against the U.S. National DNA Index System CODIS database without manual interpretation and review.

• Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System*

  8/19/2020

  In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease.

• Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.

  8/17/2020

  Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib

• Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement

  8/13/2020

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its offer to acquire all of the ordinary shares of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has lapsed. Based on information provided by the settlement agents for the offer, Deutsche Bank Aktiengesellschaft and Amer

• Thermo Fisher Scientific Supports COVID-19 Testing at Historically Black Colleges and Universities Seeking to Provide a Safe Return to Campus

  8/12/2020

  Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, has committed to supporting the efforts of historically black colleges and universities (HBCUs) in the U.S. to make COVID-19 testing available to all returning students, faculty and staff at the beginning of the fall semester.

• Thermo Fisher Scientific Provides Process Overview for the Announcement of Final Offer Results

  8/11/2020

   Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today provided an overview of the process to report the final results from the acceptance period of its offer to acquire all of the ordinary shares of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), which expired at 24:00 hours ( Frankfurt am M

• Thermo Fisher Scientific Develops COVID-19 Antibody Assay Targeting Transplant Community

  8/10/2020

  Thermo Fisher Scientific continues to expand its response to the COVID-19 pandemic, developing a new serological assay targeted towards transplant candidates and recipients that can detect antibodies directed against COVID-19 (SA

• Versatile Thermo Scientific Helios 5 PFIBs Enable Materials and Life Sciences Research

  8/6/2020

   Thermo Fisher Scientific today released the Thermo Scientific Helios 5 Plasma Focused Ion Beam (PFIB) DualBeam and the Thermo Scientific Helios 5 Hydra DualBeam focused ion beam scanning electron microscopes (

• Thermo Fisher Scientific Accelerates Nanometer-Scale Research with Next-Generation Apreo 2

  8/6/2020

  Thermo Fisher Scientific, the world leader in serving science, today unveiled its next-generation Thermo Scientific Apreo 2 Scanning Electron Microscope (SEM), a high-performance field emission SEM that takes automation to

• Thermo Fisher Scientific's COVID-19 Response Continues to Expand with New High-Throughput Automated Testing Solution

  8/5/2020

  Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day to meet increasing global demand for COVID-19 testing. The high-throughput system enables laboratories to double or even triple their te

• Thermo Fisher Scientific Confirms Offer to Acquire QIAGEN Shares Expires on August 10

  8/4/2020

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today confirmed that its offer to acquire all of QIAGEN's ordinary shares for an increased price of €43.00 per share in cash will expire at 24:00 hours

• Chemical Analyzer Now Enhances Identification of Low Dose Concentration of Illegal Substances

  7/28/2020

  Thermo Scientific Gemini Analyzer with LowDoseID for narcotics analysis eliminates concentration limitations from testing process

• Thermo Fisher Scientific Expands GlobalAccess Sequencing Program

  7/27/2020

  Company extends program benefits to oncology laboratories and fast-tracks access to comprehensive molecular profiling on the Genexus System

• FDA Clears First Blood Test for Identifying a Novel Allergic Sensitization to Red Meat

  7/23/2020

  Thermo Fisher Scientific's ImmunoCAP Specific IgE alpha-Gal Allergen Component test helps clinicians pinpoint a potentially fatal allergy often resulting from tick bites

• Thermo Fisher Scientific Reports Second Quarter 2020 Results

  7/22/2020

  Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the second quarter ended June 27, 2020.